Myrbetriq (Astellas Pharma US, Inc.)
Welcome to the PulseAid listing for the Myrbetriq drug offered from Astellas Pharma US, Inc.. This beta3-Adrenergic Agonist [EPC],Adrenergic beta3-Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Astellas Pharma US, Inc. |
| NON-PROPRIETARY NAME: | mirabegron |
| SUBSTANCE NAME: | MIRABEGRON |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | beta3-Adrenergic Agonist [EPC],Adrenergic beta3-Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-06-28 |
| END MARKETING DATE: | 0000-00-00 |
Myrbetriq HUMAN PRESCRIPTION DRUG Details:
| Item Description | Myrbetriq from Astellas Pharma US, Inc. |
| LABELER NAME: | Astellas Pharma US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2012-06-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0469-2601_6f94d8df-e362-49bc-b45e-da23f12f216c |
| PRODUCT NDC: | 0469-2601 |
| APPLICATION NUMBER: | NDA202611 |
Other MIRABEGRON Pharmaceutical Manufacturers / Labelers:
